Liposomes (NPs typically 100–500 nm in diameter) are fabricated from the self-assembly of phospholipids, which consist of a polar phosphate head group and hydrophobic lipid tails. The hydrophobic tails self-orient in aqueous environments, forming a spherical structure with an aqueous core and a lipophilic bilayer membrane surrounding it. Liposomes can be made to be both biocompatible and biodegradable (for instance, at a particular pH and temperature) by changing the lipid composition. Additionally, there are a number of modifications that can be made to liposomes to increase their effectiveness as drug delivery vehicles.
Structure | Cat No. | Product Name | CAS No. | Product Description |
---|---|---|---|---|
![]() |
V90354 | Amino-Gly-Gly-DSPE hydrochloride | 2446375-49-9 | Amino-Gly-Gly-DSPE (hydrochloride) is a specially modified phospholipid that has been used in the synthesis of liposomes. |
![]() |
V74049 | ApoA-I mimetic peptide | 221882-20-8 | ApoA-I mimetic peptide (PVLDLFRELLNELLEALKQKLK) has good lecithin:cholesterol acyltransferase (LCAT) activating effect. |
![]() |
V83421 | ATX-001 | 1777792-33-2 | |
![]() |
V74074 | ATX-002 | 1777792-34-3 | ATX-002 is an ionizable cationic lipid for RNA drug delivery. |
![]() |
V60071 | BAMEA-O16B | 2490668-30-7 | BAMEA-O16B is a lipid nanoparticles. |
![]() |
V97125 | BAmP-O16B | BAmP-O16B is an ionizable cationic amino lipid that can be used to generate lipid nanoparticles (LNPs). | |
![]() |
V101708 | Biotin-PEGn-NHS ester | 365441-71-0 | Biotin-PEGn-NHS ester is a biotin-labeled PROTAC linker that belongs to the PEG class and can be used to synthesize PROTAC molecules. |
![]() |
V90406 | Bis(2-butyloctyl) 10-oxononadecanedioate | 2036272-58-7 | Bis(2-butyloctyl) 10-oxononadecanedioate is an ionizable lipid containing four hydrophobic tails bound by esters and can be used to prepare liposomes. |
![]() |
V90431 | Bis(bis(2-carboxyethyl)aminopropyl)methylamine | 692250-70-7 | Bis(bis(2-carboxyethyl)aminopropyl)methylamine is a symmetrical branched linker with three tertiary amines and four carboxylic acids for the development of lipid nanoparticles. |
![]() |
V90408 | BP Lipid 103 | 2714482-36-5 | BP Lipid 103 is an ionizable lipid similar to SM-102 and can be used to prepare liposomes or lipid nanoparticles. |
![]() |
V90409 | BP Lipid 109 | 2569015-31-0 | BP Lipid 109 is an ionizable lipid with a long (11 carbon) lipid tail on the primary ester, two esters at the C7 position, and an ethanolamine head, which can be used to prepare liposomes or lipid nanoparticles. |
![]() |
V89582 | BP Lipid 112 | 2714482-37-6 | BP Lipid 112 is an ionizable lipid with two ester bonds at the C6 and C7 positions. |
![]() |
V90410 | BP Lipid 113 | 2714482-23-0 | BP Lipid 113 is an ionizable lipid similar to SM-102 and can be used to prepare liposomes or lipid nanoparticles. |
![]() |
V73421 | BP Lipid 114 | 2714482-25-2 | BP Lipid 114 is an ethanolamine ionizable lipid (CN113387825A). |
![]() |
V90413 | BP Lipid 126 | 2157489-64-8 | BP Lipid 126 is an ionizable lipid (Compound 143) from patent WO2017201333A1. |
![]() |
V73463 | BP Lipid 135 | 2089251-35-2 | BP Lipid 135 is a cationically ionizable lipid. |
![]() |
V90427 | BP Lipid 142 | 2244715-87-3 | BP Lipid 142 comes from patent WO2018170306A1 (Compound 261). |
![]() |
V87545 | BP Lipid 209 | 2089251-43-2 | BP Lipid 209 is an ionizable lipid that can be used to prepare liposomes or lipid nanoparticles. |
![]() |
V90428 | BP Lipid 217 | 2430034-17-4 | BP Lipid 142 is derived from patent WO2023178065A2 (B32). |
![]() |
V90412 | BP Lipid 218 | 2036272-95-2 | BP Lipid 218 is an ionizable lipid that can be used to prepare liposomes or lipid nanoparticles. |